Ophthalmology, Glaucoma Specialist · Ridgewood, NY
NPI
1164953295
Since 2017
Specialty
Ophthalmology, Glaucoma Specialist
Code 207WX0009X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
5650 Myrtle Ave
Ridgewood, NY, 11385
Phone (718) 456-9500
Groups this clinician bills Medicare through
Medicare paid, 2024
$95K
1,129 services
Medicare patients, 2024
261
Average age 75
Drug cost, 2024
$1.2M
7,871 prescriptions
Company payments, 2025
$1,341
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian D Krawitz was code 99213 (office e&m - established), 230 times for 153 patients. In total Brian D Krawitz billed 1,129 services in 31 codes, and Medicare paid $95K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 230 | 153 | $72.15 | $17K |
| 99214 Office E&M - Established | Office | 142 | 85 | $104.00 | $15K |
| 92250 Angiography | Office | 135 | 132 | $29.32 | $3,958 |
| 92014 Ophthalmological E&M | Office | 117 | 117 | $90.20 | $11K |
| 92133 Computerized Ophthalmic Imaging | Office | 96 | 92 | $30.06 | $2,885 |
| 92083 Vision, Hearing, and Speech Services | Office | 79 | 68 | $51.10 | $4,037 |
| 92134 Computerized Ophthalmic Imaging | Office | 70 | 50 | $30.60 | $2,142 |
| 92136 Ultrasound - Nonspecific | Office | 63 | 28 | $20.37 | $1,283 |
| 66984 Cataract Surgery | Facility | 24 | 13 | $446.42 | $11K |
| 92020 Ophthalmological E&M | Office | 23 | 22 | $17.24 | $397 |
| 92025 Test - Miscellaneous | Office | 22 | 22 | $30.31 | $667 |
| 92004 Ophthalmological E&M | Office | 19 | 19 | $103.19 | $1,961 |
| 76514 Ultrasound - Nonspecific | Office | 18 | 18 | $7.76 | $140 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 11 | 11 | $14.72 | $162 |
By year: 2022 $27K for 392 services; 2023 $103K for 1,175 services; 2024 $95K for 1,129 services.
Medicare prescription drug claims, 2024
In 2024, the drug Brian D Krawitz prescribed most often to Medicare patients was Latanoprost, with 1,678 prescriptions and refills. In total Brian D Krawitz wrote 7,871 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 1,678 | 2,578 | 419 | $13K |
| Brimonidine Tartrate Generic | 889 | 1,307 | 229 | $13K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 861 | 1,470 | 245 | $13K |
| Combigan Brimonidine Tartrate/Timolol | 492 | 758 | 124 | $162K |
| Dorzolamide Hcl Generic | 476 | 849 | 129 | $7,407 |
| Prednisolone Acetate Generic | 426 | 705 | 236 | $27K |
| Lumigan Bimatoprost | 412 | 655 | 96 | $175K |
| Timolol Maleate Generic | 338 | 557 | 95 | $3,728 |
| Restasis Cyclosporine | 262 | 392 | 85 | $232K |
| Rhopressa Netarsudil Mesylate | 251 | 325 | 57 | $103K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 204 | 253 | 46 | $82K |
| Simbrinza Brinzolamide/Brimonidine Tart | 168 | 210 | 40 | $35K |
| Erythromycin Erythromycin Base | 159 | 169 | 70 | $1,495 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 128 | 222 | 43 | $20K |
| Azelastine Hcl Generic | 98 | 135 | 39 | $1,445 |
Brand drugs: - claims; generic drugs: 4,766 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian D Krawitz $1,341 ($1,341 in general payments such as food, travel and fees) from 8 companies. The largest payer was Alcon Vision LLC with $553.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.